摘要
目的:自拟健脾补肾清肺经验方对矽肺临床缓解期(脾肾气虚证)患者的临床疗效。措施:把符合中、西医诊断标准的60例患者随机分成治疗组30例、对照组30例。对照组予以沙美特罗替卡松粉吸入剂500 ug,治疗组在对照组的基础上,加用自拟健脾补肾清肺经验方。2组疗程均予以12周,12周后观察临床症状、临床疗效、肺功能。结果:1) 临床症候:治疗后总有效率治疗组以及对照组均有改善,且治疗组(80.0%)优于对照组(70.0%),差异有统计学意义(P 0.05)。3) mMRC评分:治疗后mMRC治疗组以及对照组均有改善,且治疗组优于对照组,差异有统计学意义(P < 0.05)。结论:自拟健脾补肾清肺经验方能缓解矽肺临床缓解期(脾肾气虚证)患者的临床症状、肺功能,有较好的临床疗效。
Objective: The clinical efficacy of a self-designed empirical formula for strengthening the spleen, tonifying the kidney, and clearing the lung in patients with clinical remission of silicosis (spleen kidney qi deficiency syndrome). Method: Randomly divide 60 patients who meet the diagnostic cri-teria of Chinese and Western medicine into a treatment group of 30 cases and a control group of 30 cases. The control group received 500 ug of salmeterol and fluticasone powder inhalation, while the treatment group received a self formulated experience formula for strengthening the spleen, toni-fying the kidneys, and clearing the lungs on the basis of the control group. Both groups were treated for 12 weeks, and after 12 weeks, clinical symptoms, clinical efficacy, and lung function were ob-served. Result: 1) Clinical symptoms: The total effective rate of the treatment group and the control group improved after treatment, and the treatment group(80.0%) was better than the control group (70.0%), with a statistically significant difference (P 0.05). 3) mMRC score: After treatment, both the mMRC treatment group and the control group improved, and the treatment group was better than the control group, with a statis-tically significant difference (P < 0.05). Conclusion: The self formulated experience of strengthening the spleen, tonifying the kidney, and clearing the lung can alleviate the clinical symptoms and lung function of patients in the clinical remission stage of silicosis (spleen kidney qi deficiency syn-drome), and has good clinical efficacy.
出处
《医学诊断》
2023年第2期231-236,共6页
Medical Diagnosis
